WITNESSETH:Lease Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
RECITALSStockholder Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
WITNESSETH:Lease • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.20 EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the date last written below by and between Genencor International, Inc. ("GCOR"), a Delaware Corporation with a principal office at 925 Page Mill Road, Palo Alto, California 94104-1013 and...Employment Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 4.9 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 5 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.31 FIRST AMENDMENT OF THE COLLABORATION AGREEMENT This First Amendment (this "FIRST AMENDMENT") to the Collaboration Agreement is made and entered into as of October 16, 2002 by and between EPIMMUNE INC., having a principal place of...Collaboration Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
RECITALSStockholder Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
AMENDMENT NO. 2 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
EXHIBIT 10.16 AGREEMENT FOR THE FIRST AMENDMENT TO THE AMENDED AND RESTATED EQUITY JOINT VENTURE CONTRACT AND FIRST AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION THIS AGREEMENT FOR THE FIRST AMENDMENT TO THE AMENDED AND RESTATED EQUITY...Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
EXHIBIT 4.7 GENENCOR INTERNATIONAL, INC. AMENDMENT NO. 3 TO NOTE AGREEMENTNote Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
December 17, 2002 [GENENCOR INTERNATIONAL LOGO] 925 Page Mill Road Palo Alto California 94304 Re: Letter Agreement 650.846.7500 650.845.6500 fax www.genencor.com Dear Debby Jo, For reasons we previously discussed, your employment with Genencor...Competition Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
FIRST AMENDMENT OF THE LICENSE AGREEMENT This First Amendment (this "FIRST AMENDMENT") to the License Agreement is made and entered into as of October 16, 2002 by and between EPIMMUNE INC., having a principal place of business at 5820 Nancy Ridge...License Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances
AMENDMENT NO. 1 TO NOTE AGREEMENT This AMENDMENT NO. 1 TO NOTE AGREEMENT (this "Amendment"), dated as of September 25, 1996, is made by and among GENENCOR INTERNATIONAL, INC., a Delaware corporation (together with its successors and assigns, the...Note Agreement • March 26th, 2003 • Genencor International Inc • In vitro & in vivo diagnostic substances • New York
